Endothelial dysfunction in hyperandrogenic polycystic ovary syndrome is not explained by either obesity or ectopic fat deposition

Clinical Science

Volumn 126, Issue 1, 2014, Pages 67-74

  Sprung, Victoria S ^a   Jones, Helen ^a   Pugh, Christopher J A ^a,b   Aziz, Nabil F ^c   Daousi, Christina ^d   Kemp, Graham J ^d   Green, Daniel J ^a,b   Cable, N Timothy ^a   Cuthbertson, Daniel J ^d  

^a LIVERPOOL JOHN MOORES UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c LIVERPOOL WOMEN S HOSPITAL   (United Kingdom)

^d UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Adiposity; Cardiovascular disease; Endothelial function; Obesity; Polycystic ovary syndrome

Indexed keywords

GLUCOSE; INSULIN; TESTOSTERONE; TRIACYLGLYCEROL;

ADULT; ANTHROPOMETRY; ARTICLE; BODY FAT; BODY FAT DISTRIBUTION; BRACHIAL ARTERY; BREATH ANALYSIS; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; FEMALE; HUMAN; HYPERANDROGENISM; INSULIN RESISTANCE; LIPID STORAGE; LIVER; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OBESITY; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SKELETAL MUSCLE; TESTOSTERONE BLOOD LEVEL; VASODILATATION; WAIST CIRCUMFERENCE; WHOLE BODY MRI;

ADIPOSE TISSUE; ADIPOSITY; ADULT; ANTHROPOMETRY; BRACHIAL ARTERY; CASE-CONTROL STUDIES; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; HYPERANDROGENISM; INSULIN RESISTANCE; LIVER; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MUSCLE, SKELETAL; OBESITY; POLYCYSTIC OVARY SYNDROME; PROGNOSIS; TRIGLYCERIDES; VASODILATION; YOUNG ADULT;

EID: 84885036040     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20130186     Document Type: Article

References (45)

1. Goodarzi, M. O., Dumesic, D. A., Chazenbalk, G. and Azziz, R. (2011) Polycystic ovary syndrome: etiology, pathogenesis and diagnosis. Nat. Rev. Endocrinol. 7, 219-231
2. Azziz, R., Woods, K. S., Reyna, R., Key, T. J., Knochenhauer, E. S. and Yildiz, B. O. (2004) The prevalence and features of the polycystic ovary syndrome in an unselected population. J. Clin. Endocrinol. Metab. 89, 2745-2749
3. Broekmans, F. J., Knauff, E. A., Valkenburg, O., Laven, J. S., Eijkemans, M. J. and Fauser, B. C. (2006) PCOS according to the Rotterdam consensus criteria: change in prevalence among WHO-II anovulation and association with metabolic factors. Br. J. Obstet. Gynaecol. 113, 1210-1217
4. Sprung, V. S., Atkinson, G., Cuthbertson, D. J., Pugh, C. J., Aziz, N., Green, D. J., Cable, N. T. and Jones, H. (2013) Endothelial function measured using flow-mediated dilation in polycystic ovary syndrome: a meta-analysis of the observational studies. Clin. Endocrinol. 78, 438-446
5. Schmidt, J., Landin-Wilhelmsen, K., Brannstrom, M. and Dahlgren, E. (2011) Cardiovascular disease and risk factors in PCOS women of postmenopausal age: a 21-year controlled follow-up study. J. Clin. Endocrinol. Metab. 96, 3794-3803
6. Fauser, B. C., Tarlatzis, B. C., Rebar, R. W., Legro, R. S., Balen, A. H., Lobo, R., Carmina, E., Chang, J., Yildiz, B. O., Laven, J. S. et al. (2012) Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-sponsored 3rd PCOS Consensus Workshop Group. Fertil. Steril. 97, 28-38 e25
7. de Groot, P. C., Dekkers, O. M., Romijn, J. A., Dieben, S. W. and Helmerhorst, F. M. (2011) PCOS, coronary heart disease, stroke and the influence of obesity: a systematic review and meta-analysis. Hum. Reprod. Update 17, 495-500
8. Thijssen, D. H., Black, M. A., Pyke, K. E., Padilla, J., Atkinson, G., Harris, R. A., Parker, B., Widlansky, M. E., Tschakovsky, M. E. and Green, D. J. (2011) Assessment of flow-mediated dilation in humans: a methodological and physiological guideline. Am. J. Physiol. Heart Circ. Physiol. 300, H2-H12
9. Green, D. J., Jones, H., Thijssen, D., Cable, N. T. and Atkinson, G. (2011) Flow-mediated dilation and cardiovascular event prediction: does nitric oxide matter? Hypertension 57, 363-369
10. Sorensen, M. B., Franks, S., Robertson, C., Pennell, D. J. and Collins, P. (2006) Severe endothelial dysfunction in young women with polycystic ovary syndrome is only partially explained by known cardiovascular risk factors. Clin. Endocrinol. 65, 655-659
11. Kravariti, M., Naka, K. K., Kalantaridou, S. N., Kazakos, N., Katsouras, C. S., Makrigiannakis, A., Paraskevaidis, E. A., Chrousos, G. P., Tsatsoulis, A. and Michalis, L. K. (2005) Predictors of endothelial dysfunction in young women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 90, 5088-5095
12. Carmina, E., Orio, F., Palomba, S., Longo, R. A., Cascella, T., Colao, A., Lombardi, G., Rini, G. B. and Lobo, R. A. (2006) Endothelial dysfunction in PCOS: role of obesity and adipose hormones. Am. J. Med. 119, e351-e356
13. Jones, H., Sprung, V. S., Pugh, C. J., Daousi, C., Irwin, A., Aziz, N., Adams, V. L., Thomas, E. L., Bell, J. D., Kemp, G. J. and Cuthbertson, D. J. (2012) Polycystic ovary syndrome with hyperandrogenism is characterized by an increased risk of hepatic steatosis compared to nonhyperandrogenic PCOS phenotypes and healthy controls, independent of obesity and insulin resistance. J. Clin. Endocrinol. Metab. 97, 3709-3716
14. Cascella, T., Palomba, S., De Sio, I., Manguso, F., Giallauria, F., De Simone, B., Tafuri, D., Lombardi, G., Colao, A. and Orio, F. (2008) Visceral fat is associated with cardiovascular risk in women with polycystic ovary syndrome. Hum. Reprod. 23, 153-159
15. Zawadzki, J. and Dunaif, A. (1992) Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. Polycystic Ovary Syndrome, Blackwell Scientific, Boston 377-384
16. Azziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Futterweit, W., Janssen, O. E., Legro, R. S., Norman, R. J., Taylor, A. E. et al. (2006) Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J. Clin. Endocrinol. Metab. 91, 4237-4245
17. Jones, H., Green, D. J., George, K. and Atkinson, G. (2010) Intermittent exercise abolishes the diurnal variation in endothelial-dependent flow-mediated dilation in humans. Am. J. Physiol. Regul. Integr. Comp. Physiol. 298, R427-R432
18. Mathur, R. S., Moody, L. O., Landgrebe, S. and Williamson, H. O. (1981) Plasma androgens and sex hormone-binding globulin in the evaluation of hirsute females. Fertil. Steril. 35, 29-35
19. Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F. and Turner, R. C. (1985) Homeostasis model assessment: insulin resistance and ß-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412-419
20. Black, M. A., Cable, N. T., Thijssen, D. H. and Green, D. J. (2008) Importance of measuring the time course of flow-mediated dilatation in humans. Hypertension 51, 203-210
21. Parker, B. A., Trehearn, T. L. and Meendering, J. R. (2009) Pick your Poiseuille: normalizing the shear stimulus in studies of flow-mediated dilation. J. Appl. Physiol. 107, 1357-1359
22. Green, D., Cheetham, C., Reed, C., Dembo, L. and O'Driscoll, G. (2002) Assessment of brachial artery blood flow across the cardiac cycle: retrograde flows during cycle ergometry. J. Appl. Physiol. 93, 361-368
23. Woodman, R. J., Playford, D. A., Watts, G. F., Cheetham, C., Reed, C., Taylor, R. R., Puddey, I. B., Beilin, L. J., Burke, V., Mori, T. A. et al. (2001) Improved analysis of brachial artery ultrasound using a novel edge-detection software system. J. Appl. Physiol. 91, 929-937
24. Bruce, R. A., Kusumi, F. and Hosmer, D. (1973) Maximal oxygen intake and nomographic assessment of functional aerobic impairment in cardiovascular disease. Am. Heart. J. 85, 546-562
25. Burkhalter, N. (1996) Evaluation of Borg's perceived exertion scale in cardiac rehabilitation. Rev. Lat. Am. Enfermagem. 4, 65-73
26. Borg, G. (1998) Borg's Perceived Exertion and Pain Scales, Human Kinetics Publishers, Champaign, IL
27. Szczepaniak, L. S., Nurenberg, P., Leonard, D., Browning, J. D., Reingold, J. S., Grundy, S., Hobbs, H. H. and Dobbins, R. L. (2005) Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. Am. J. Physiol. Endocrinol. Metab. 288, E462-E468
28. Atkinson, G., Batterham, A. M., Thijssen, D. H. and Green, D. J. (2013) A new approach to improve the specificity of flow-mediated dilation for indicating endothelial function in cardiovascular research. J. Hypertens. 31, 287-291
29. Atkinson, G. and Batterham, A. M. (2013) Allometric scaling of diameter change in the original flow-mediated dilation protocol. Atherosclerosis 226, 425-427
30. Inaba, Y., Chen, J. A. and Bergmann, S. R. (2010) Prediction of future cardiovascular outcomes by flow-mediated vasodilatation of brachial artery: a meta-analysis. Int. J. Cardiovasc. Imaging 26, 631-640
31. Panagiotakos, D. B., Pitsavos, C., Yannakoulia, M., Chrysohoou, C. and Stefanadis, C. (2005) The implication of obesity and central fat on markers of chronic inflammation: The ATTICA study. Atherosclerosis 183, 308-315
32. Iacobellis, G. (2005) Imaging of visceral adipose tissue: an emerging diagnostic tool and therapeutic target. Curr. Drug Targets Cardiovasc. Haematol. Disord. 5, 345-353
33. Green, D. J., O'Driscoll, G., Joyner, M. J. and Cable, N. T. (2008) Exercise and cardiovascular risk reduction: time to update the rationale for exercise? J. Appl. Physiol. 105, 766-768
34. Green, D. J., Walsh, J. H., Maiorana, A., Best, M. J., Taylor, R. R. and O'Driscoll, J. G. (2003) Exercise-induced improvement in endothelial dysfunction is not mediated by changes in CV risk factors: pooled analysis of diverse patient populations. Am. J. Physiol. Heart Circ. Physiol. 285, H2679-H2687
35. El-Kannishy, G., Kamal, S., Mousa, A., Saleh, O. and Badrawy, A. E. (2010) Endothelial function in young women with polycystic ovary syndrome (PCOS): Implications of body mass index (BMI) and insulin resistance. Obes. Res. Clin. Pract. 4, e49-e56
36. Paradisi, G., Steinberg, H. O., Hempfling, A., Cronin, J., Hook, G., Shepard, M. K. and Baron, A. D. (2001) Polycystic ovary syndrome is associated with endothelial dysfunction. Circulation 103, 1410-1415
37. Empen, K., Lorbeer, R., Dörr, M., Haring, R., Nauck, M., Gläser, S., Krebs, A., Reffelmann, T., Ewert, R. and Völzke, H. (2012) Association of testosterone levels with endothelial function in men. Arterioscler. Thromb. Vasc. Biol. 32, 481-486
38. Azziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Futterweit, W., Janssen, O. E., Legro, R. S., Norman, R. J., Taylor, A. E. et al. (2009) The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil. Steril. 91, 456-488
39. Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum. Reprod. 19, 41-47
40. Birk, G. K., Dawson, E. A., Atkinson, C., Haynes, A., Cable, N. T., Thijssen, D. H. and Green, D. J. (2012) Brachial artery adaptation to lower limb exercise training: role of shear stress. J. Appl. Physiol. 112, 1653-1658
41. Abdul-Ghani, M. A., Matsuda, M., Balas, B. and DeFronzo, R. A. (2007) Muscle and liver insulin resistance indexes derived from the oral glucose tolerance test. Diabetes Care 30, 89-94
42. Shojaee-Moradie, F., Baynes, K. C., Pentecost, C., Bell, J. D., Thomas, E. L., Jackson, N. C., Stolinski, M., Whyte, M., Lovell, D., Bowes, S. B. et al. (2007) Exercise training reduces fatty acid availability and improves the insulin sensitivity of glucose metabolism. Diabetologia 50, 404-413
43. Brinkworth, G. D., Noakes, M., Moran, L. J., Norman, R. and Clifton, P. M. (2006) Flow-mediated dilatation in overweight and obese women with polycystic ovary syndrome. Br. J. Obstet. Gynaecol. 113, 1308-1314
44. Cussons, A. J., Watts, G. F. and Stuckey, B. G. (2009) Dissociation of endothelial function and arterial stiffness in nonobese women with polycystic ovary syndrome (PCOS). Clin. Endocrinol. 71, 808-814
45. Soares, G. M., Vieira, C. S., Martins, W. P., Franceschini, S. A., dos Reis, R. M., Silva de Sa, M. F. and Ferriani, R. A. (2009) Increased arterial stiffness in nonobese women with polycystic ovary syndrome (PCOS) without comorbidities: one more characteristic inherent to the syndrome? Clin. Endocrinol. 71, 406-411